Appendix Materials and Methods

Plasmids and short hairpin RNA (shRNA)
Full-length human VPS15, Beclin1 (untagged), Flag-tagged VPS34, Flag-tagged UVRAG, GFP-fused ATG14L, GFP-fused DFCP1 were purchased from Addgene (Cambridge, MA, USA). Among these plasmids, VPS15, ATG14L and Beclin1 were sub-cloned into p3Xflag-CMV-10 vector (Sigma-Aldrich, St. Louis, MO, USA). Beclin1 was also inserted into pRK-5 mammalian expression vector (BD biosciences) with a GST tag added to the N-terminus by a PCR-based method. Plasmids of the Flag-tagged AMPK1 as well as its dominant negative (DN) and constitutive active (CA) forms were provided by Dr. Yu Li (Institute for Nutritional Sciences, SIBS, CAS, China). For mapping their interaction domains with PAQR3, diverse truncations of ATG14L and Beclin1 were inserted into EGFP-C1 vector. Myc-tagged PAQR3, and PAQR3-shRNA have been described as previously reported (Feng et al, 2007; Jiang et al, 2010; . Multiple PAQR3 deletions were sub-cloned into PCMV-tag3 vector by overlap extension PCR. For prokaryotic expression and purification, the NH2-terminal 71 amino acids of PAQR3 (or multiple mutations) were inserted into the bacterial expression construct (PET28+). Point mutations of PAQR3 were performed by a PCR-based site-directed mutagenesis method using Pfu polymerase (Stratagene).
The lentivirus-based vectors pLVX-Puro and pHAGE-fullEF1a-MCS-IZsGreen were used for stable expression of GFP-DFCP1 and PAQR3 in HeLa cells respectively. The ATG5, ATG7 and ATG14L short hairpin RNA (shRNA) was constructed by a lentiviral system as previously reported (Qin et al, 2003) . The sequences for constructing two independent shRNAs against human ATG14L were 5'-GGCAAATCTTCGACGATCCCATATA-3' and 5'-GATCACAACGGAGACACCAGCATTA-3' respectively. The shRNA-resistant expression plasmid of ATG14L, PAQR3 and NRBF2 were constructed by same-sense mutations at the targeting sequence of their cDNA. Human ATG5 and ATG7 shRNA sequence were 5'-GGTTTGGACGAATTCCAACTTGTTT-3' and 5'-GCCGTCATTGCTGCAAGCAAGAGAA -3' respectively. The target sequences of 3 human PAQR3-and NRBF2-shRNAs were both reported previously Zhong et al, 2014) . The expression plasmids used in the study were generated according to standard molecular biology techniques. All the plasmids were subjected to sequencing verification. PAQR3-deleted mouse embryos was described previously (Feng et al, 2007) . We generated PAQR3-deficient HeLa cells using a CRISPR/Cas9 system as previously reported (Cong et al, 2013; Mali et al, 2013) . The sequences of two PAQR3-targetting 
Antibodies and reagents
Antibodies used in the immunoblotting were as follows: LC3 (#2775), SQSTM1/p62 
Co-immunoprecipitation and two-step co-immunoprecipitation
For co-immunoprecipitation (Co-IP) assays, cells were washed three times and then lysed with a mild lysis buffer [10 mM Tris, pH7.5, 2 mM EDTA, 100 mM NaCl, 1% NP-40, 50 mM NaF, 1 mM Na3VO4, and protease inhibitor cocktail (Roche)] for 30 min at 4°C. The homogenates were centrifuged for 30 min at 12,000 rpm at 4°C. 10% of the supernatant was harvested for Western blotting analysis as inputs, while the remaining cell lysate was incubated with primary antibodies overnight at 4°C. Protein A/G plus agarose (Genescript) was added at 4°C for 2 h. The resulting beads were washed with IP buffer 5 for 5 times, followed by Western blotting analysis. For IP of skeletal muscles and liver, tissues was dissected and homogenized in lysis buffer containing 50 mM Tris (pH 7.9), 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, proteinase inhibitor cocktail (Roche Applied Sciences) and halt phosphatase inhibitor cocktail (Thermo Scientific). The two-step co-IP assays were performed as previously reported (Harada et al, 2003; Rui et al, 2004) .
Immunofluorescence staining, protein co-localization quantitation and fractionation of Golgi membranes
Confocal microscopy analysis was performed as previously reported (Feng et al, 2007) . isolated from the mouse liver as reported previously (Bartz et al, 2008; Wang et al, 2013; Wei & Seemann, 2009 ).
Gel filtration analysis
Gel filtration analysis was performed as described previously (Ma et al, 2014) . In short, liver tissues were extracted and homogenized in ice-cold homogenization buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.1% Triton X-100, 1 mM PMSF, complete protease inhibitor cocktail (Roche) and phosphatase inhibitors), and then followed by sonication for 2 min on ice. The homogenate was subjected to low-speed centrifugation at 17,000g
for 5 min and then ultracentrifuged at 100,000g for 60 min. After pro-filtration with a 0.22 µm pore size hydrophilic polyethersulfone (PES) membrane, the resulting 6 supernatants were applied to a Superose 6 10/300 GL column using fast protein liquid chromatography (GE Healthcare) and eluted at a flow rate of 0.5 ml/min. The fractions were finally precipitated with trichloroacetic acid (TCA) and examined by immunoblotting.
LC−MS/MS analysis
For analysis of PAQR3 phosphorylation sites, bacterial purified His-tagged NH2-terminal 71aa of PAQR3 was subjected to AMPK kinase assay in vitro. Then the protein sample was purified, and precipitated by trichloric acid followed by acetone washing. The pellets were solubilized and reduced in a buffer containing 7 M urea, 2 M thiourea, 10 mM HEPES, 1 mM sodium orthoranadate, 5 mM sodium fluoride, 5 mM -glycerophosphate, and 10 mM DTT, pH 8.0, then alkylated with 50 mM iodoacetamide. After reducing urea concentration to 2 M, the samples were digested with trypsin (Promega, USA) at 37°C
(1:100 w/w) overnight. The digested peptide mixtures were acidified with trifluoroacetic acid (TFA) at 1% final concentration and desalted by reversed-phase C18 Sep-Pak cartridge (Millipore, USA). Phosphopeptides were enriched using TiO2 beads (Titansphere, GL Sciences, Japan) in 80% acetonitrile (ACN) and 0.5% acetic acid in 3,4-dihydroxybenzoic acid solution. After a serial wash with buffer 1 (5 mM KH2PO4, 30% ACN, 350 mM KCl), buffer 2 (40% ACN, 0.5% acetic acid, 0.05% TFA) and buffer 3 (80% ACN, 0.5% acetic acid), the phosphorylated peptides were eluted first with 5% NH4OH
followed by 10% NH4OH in 25% ACN. Eluted peptides were concentrated in a speedVac and desalted using C18 STAGE-tip. The samples were analyzed on an EASY-nLC1000
LC system (Thermo Scientific) coupled to the Q-Exactive mass spectrometer (Thermo Scientific). Peptides were loaded on an in-house packed C18-column (15 cm, 75 m I.D., 2 m particle size) with a gradient of 12%-32% buffer B (98% acetonitrile, 0.1% acetic acid) in 30 min followed by a 5 min wash with 95% buffer B. Full scan MS spectra were acquired at a resolution of 70,000 with an AGC target value of 3×10 6 and a maximum injection time of 100 ms. MS/MS spectra were acquired at a resolution of 17,500 with a target value of 1×10 5 and a maximum injection time of 50 ms. The raw files were processed by the MaxQuant software (version 1.5.3.8) searching against the Uniprot database, with a variable modification of serine, threonine and tyrosine phosphorylation.
For analyzing the stoichiometric binding partners of PAQR3, Myc-tagged PAQR3
immunoprecipitated from the PAQR3-reconstituted HeLa cells were eluted by Myc peptide and subjected to silver staining. Specific bands were exercised and digested in the gel with trypsin, and the resulting peptide mixtures were analyzed by LC-MS/MS. The MS/MS spectra were searched against the non-redundant human protein sequence database at the National Center for Biotechnology Information (NCBI).
Mouse behavioral studies
All mice used in behavioral testing experiment were housed in the same situation to avoid environmental biasing. The following tests were carried out on 11-month-old male PAQR3 knockout mice. The limb clasping phenotype was measured by suspending each mouse by its tail for 30 s and a clasping score of 0-3 was given as described previously (Cyr et al, 2003) : 0, no clasping; 1, paw clenching and abnormal extension of the hindlimbs were noticed; 2, mild clasping (only fore or hind limbs press into the stomach); 3, severe clasping (both fore and hind limbs touch and press into the stomach). The accelerating rotarod test was performed on a standard accelerating rotarod device (Panlab, Harvard Apparatus) as previously described (Dang et al, 2006) . Briefly, mice were trained to use the rotarod apparatus during a habituation trial at 4 rpm before testing. On the testing day, after mice were placed onto a horizontal rotating rod, the rotarod was accelerated from 4 to 40 rpm at a rate of 0.2 rpm/s. Mice were tested for two consecutive days, receiving three trials per day with 1 h intertribal interval. The time of mouse spent on the rotating rod until it fell off was recorded. Gait analysis was detected as previously described (Cyr et al, 2003) . Briefly, the fore and hind paws of mice were painted with nontoxic red and blue paint respectively, and then the mice were allowed to walk across an uncovered corridor lined with paper. Paw prints were scanned using scanner and analyzed by measuring the stride length and gait width. Grip strength analysis was performed as previously described (Mandillo et al, 2008) . Briefly, mice were handled by their tails and placed over the grid until all 4 paws grasped the grid of the grip strength test meter (BIOSEB; EB Instruments). The tail was then pulled in parallel with the mouse 8 body until the mouse released hold entirely. The maximum force was digitally displayed in grams. Five separate readings of each mouse were recorded and averaged.
